Biostatistics, Singapore Clinical Research Institute, Singapore; Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore; Centre for Child Health Research, Tampere University, Finland.
Department of Cardiology, National Heart Centre Singapore, Singapore.
Value Health. 2022 Mar;25(3):451-460. doi: 10.1016/j.jval.2021.09.010. Epub 2021 Nov 25.
Several studies have shown that patients with heart disease value hypothetical health states differently from the general population. We aimed to investigate the health preferences of patients with heart disease and develop a value set for the 5-level EQ-5D (EQ-5D-5L) based on these patient preferences.
Patients with confirmed heart disease were recruited from 2 hospitals in Singapore. A total of 86 EQ-5D-5L health states (10 per patient) were valued using a composite time trade-off method according to the international valuation protocol for EQ-5D-5L; 20-parameter linear models and 8-parameter cross-attribute level effects models with and without an N45 term (indicating whether any health state dimension at level 4 or 5 existed) were estimated. Each model included patient-specific random intercepts. Model performance was evaluated for out-of-sample and in-sample predictive accuracy in terms of root mean square error. The discriminative ability of the utility values was assessed using heart disease-related functional classes.
A total of 576 patients were included in the analysis. The preferred model, with the lowest out-of-sample root mean square error, was a 20-parameter linear model including N45. Predicted utility values ranged from -0.727 for the worst state to 1 for full health; the value for the second-best state was 0.981. Utility values demonstrated good discriminative ability in differentiating among patients of varied functional classes.
An EQ-5D-5L value set representing the preferences of patients with heart disease was developed. The value set could be used for patient-centric economic evaluation and health-related quality of life assessment for patients with heart disease.
多项研究表明,心脏病患者对假设健康状况的评价与一般人群不同。我们旨在调查心脏病患者的健康偏好,并基于这些患者的偏好为 EQ-5D-5L 制定一个价值体系。
从新加坡的 2 家医院招募了确诊为心脏病的患者。根据 EQ-5D-5L 的国际评估协议,使用综合时间权衡法对 86 个 EQ-5D-5L 健康状况(每位患者 10 个)进行了评估;还估计了带有和不带有 N45 项(表示 4 级或 5 级的任何健康状况维度是否存在)的 20 参数线性模型和 8 参数交叉属性水平效应模型。每个模型都包含患者特定的随机截距。根据均方根误差,评估了模型在样本外和样本内的预测准确性。使用与心脏病相关的功能类别评估效用值的判别能力。
共纳入 576 例患者进行分析。具有最低样本外均方根误差的首选模型是一个包含 N45 的 20 参数线性模型。预测的效用值范围从最差状态的-0.727 到完全健康的 1;第二好状态的效用值为 0.981。效用值在区分不同功能类别的患者方面表现出良好的判别能力。
制定了一个代表心脏病患者偏好的 EQ-5D-5L 值集。该值集可用于以患者为中心的经济评估和心脏病患者的健康相关生活质量评估。